Literature DB >> 26467148

Optimal designs for a multiresponse Emax model and efficient parameter estimation.

Bergrun T Magnusdottir1.   

Abstract

The aim of dose finding studies is sometimes to estimate parameters in a fitted model. The precision of the parameter estimates should be as high as possible. This can be obtained by increasing the number of subjects in the study, N, choosing a good and efficient estimation approach, and by designing the dose finding study in an optimal way. Increasing the number of subjects is not always feasible because of increasing cost, time limitations, etc. In this paper, we assume fixed N and consider estimation approaches and study designs for multiresponse dose finding studies. We work with diabetes dose-response data and compare a system estimation approach that fits a multiresponse Emax model to the data to equation-by-equation estimation that fits uniresponse Emax models to the data. We then derive some optimal designs for estimating the parameters in the multi- and uniresponse Emax model and study the efficiency of these designs.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Dose-response studies; Multiresponse Emax models; Optimal designs; Precise parameter estimates; System estimation

Mesh:

Year:  2015        PMID: 26467148     DOI: 10.1002/bimj.201400203

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  2 in total

1.  Quantitative Comparison of the Clinical Efficacy of 6 Classes Drugs for IgA Nephropathy: A Model-Based Meta-Analysis of Drugs for Clinical Treatments.

Authors:  Jiesen Yu; Jieren Luo; Haoxiang Zhu; Zichao Sui; Hongxia Liu; Lujin Li; Qingshan Zheng
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

2.  Population Pharmacodynamic Analyses of Human Anti-Rabies Virus Monoclonal Antibody (Ormutivimab) in Healthy Adult Subjects.

Authors:  Junnan Zhang; Nianmin Shi; Guohua Li; Li Li; Yunhua Bai; Liqing Yang; Weimin Zhao; Jian Gao; Jingshuang Wei; Wei Zhao; Lili Zhai; Peiyuan Huo; Lemin Ren; Lan Yu; Yufeng Li
Journal:  Vaccines (Basel)       Date:  2022-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.